WAVE Life Sciences (WVE) Tops Q3 EPS by 25c

WAVE Life Sciences (NASDAQ: WVE) reported Q3 EPS of $0.07, $0.25 better than the analyst estimate of ($0.18). Revenue for the quarter came in at $49.2 million versus the consensus estimate of $23.43 million.

For earnings history and earnings-related data on WAVE Life Sciences (WVE) click here.

You May Also Be Interested In

• Lindsay (LNN) Tops Q3 EPS by 18c, Misses on Revenue
• APi Group closes WTech Fire Group deal, raises 2026 guidance
• Franklin Covey (FC) Misses Q3 EPS by 2c, lowers Guidance